Hi Dhm
Are you asking about Azer-cel?
Not sure which video you are referring to, but if it was mid year, then probably Yuman and Bradley were speaking at different times about different products.
Azer-cel, now licensed to Imugene, is manufactured from healthy T cells donated by healthy patients, and then genetically modified to make it compatible with any patient.
Yuman was probably referring to Cycart-19, which is the Allogenic CD19 CART produced by Celularity - which is also being investigated as a potential combination therapy with OnCARlytics. CYCART-19 is indeed priced from human placenta tissue.
Preclinical trials of CYCART-19 with OnCARlytics were very promising, and I believe Celularity is still interested in pursuing this further - though now that IMU has Azer-cel I would think that is a higher priority for the company.
Cheers
Dave
Why IMU is a multi multi bagger, page-19876
-
- There are more pages in this discussion • 7,027 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
4.8¢ |
Change
0.000(0.00%) |
Mkt cap ! $356.9M | |||
| Open | High | Low | Value | Volume |
| 4.8¢ | 4.9¢ | 4.8¢ | $573.9K | 11.93M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 41 | 6251688 | 4.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 4.9¢ | 3022777 | 8 |
View Market Depth
| Last trade - 16.10pm 10/10/2024 (20 minute delay) ? |
| IMU (ASX) Chart |